Biological Mimetics, Inc. Email Format
Biotechnology ResearchMaryland, United States2-10 Employees
Biological Mimetics, Inc. is a small biotechnology research company based in Frederick, Maryland. The firm focuses on developing and commercializing biologics for human and veterinary medicine, aiming to address resistant and emerging diseases across viruses, bacteria, parasites, and cancer. The company has developed a technology platform, Immune Refocusing Technology (IRT), built on an understanding of deceptive imprinting, a mechanism of antigenic variation used by certain pathogens and cancer cells to evade the immune system. Its researchers describe IRT as a means to alter the natural antigenicity and immunogenicity of targeted protein antigens, with applications to vaccines that currently have limited protection and to vaccines for pathogens without effective options. The approach is also positioned to support the generation of monoclonal antibodies and, in some contexts, to modulate therapeutic proteins to improve their half-life and safety profiles. BMI operates with a small team in the biotechnology sector, applying its platform to human and veterinary biological products.